Paige Mahaney

Paige Mahaney is a prominent leader in the pharmaceutical and biotechnology sectors, currently serving as Chief Scientific Officer at C4 Therapeutics, Inc. since October 2024, and as a Scientific Advisory Board Member at Eurofins Discovery since May 2022. Mahaney has extensive experience, having held key roles including SVP and Head of Drug Discovery at Exelixis from June 2021 to October 2024, and SVP and Discovery Research Site Head at Boehringer Ingelheim from June 2009 to June 2021, where responsibilities encompassed overseeing research productivity across multiple therapeutic areas and leading global biotherapeutics discovery. Mahaney's earlier career includes significant contributions at Wyeth and Hoffmann-La Roche, culminating in the advancement of pivotal drug candidates. Mahaney holds a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technology and a B.S. in Chemistry, Biology, and Physics from Guilford College.